In the Democratic Republic of the Congo, a second vaccine against for more than a year of rampant Ebola virus comes to use. For the U.S. group Johnson & Johnson produced vaccine will be used in Goma in the East of the country, said the aid organization Doctors without borders (MSF).
Within four months, therefore, of 50,000 men should be vaccinated in the city. The effectiveness of the new vaccine has been confirmed, according to MSF figures so far, only in clinical Tests, under real conditions it was tested before.
More than 250,000 people have been vaccinated since the beginning of August of 2018, with other means of the pharmaceutical company Merck. The world health organization (WHO) had pushed for the introduction of a second vaccine. This should not replace according to MSF the previous vaccine by Merck, but the treatment options expand.
The current Ebola epidemic was on 1. August 2018 broken out. It is already the tenth in the country. Is mainly affected the East of the country, where several militias are active and the work of the helpers make it difficult. In July, the WHO had to call in response to the international health emergency. So far, more than 3000 people at the outbreak with the outbreak is sick with Ebola, more than 2000 have died.
The Ebola virus was for the first time in 1976 in the North of the Democratic Republic of the Congo registered, and is named after a local river. The Infected suffer from fever, muscle pain, failure, diarrhea, and internal bleeding and eventually organ.